Tweet
Reuters |
Biotechs climb after two-day drop Reuters NEW YORK (Reuters) - Biotech stocks are moving higher on Wednesday, bouncing back from a two-day drop, helped by gains in Gilead Sciences (GILD.O) after trial results for the company's HIV treatment. Gilead said its HIV tablet containing tenofovir ... Gilead's Next-Gen HIV Drug Bests Stribild In TrialsInvestor's Business Daily Gilead's Latest HIV Pill Meets Study GoalsWall Street Journal Gilead's HIV drug shows potential in two mid-stage studiesWHBL Sheboygan Monthly Prescribing Reference -RTT News all 27 news articles » |
More...